$0.58 -0.00 (-0.514%) Cesca Therapeutics Inc - NASDAQ

Oct. 7, 2015 | 11:34 AM

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
9/17/2015BRUCH MICHAELInterim CFO-9,915$0.65-7.95%
9/10/2015BRUCH MICHAELInterim CFO20,000$0.6319.09%
9/02/2015Plavan Matthew TFormer CEO-5,871$0.69-2.34%
9/02/2015Plavan Matthew TFormer CEO-11,400$0.68-4.35%
6/30/2015Rao Mahendra S.Director4,412$0.8545.38%
6/30/2015MOORE CRAIG WDirector5,846$0.857.22%
6/09/2015STRACEY ROBIN CCEO1,000,000$0.831,983.93%
3/31/2015MOORE CRAIG WDirector5,799$0.907.71%
2/18/2015Sivilotti MitchelSubstantial Shareholder-6,692$0.88-0.14%
2/18/2015Harris KennethPresident-6,692$0.88-0.15%
12/31/2014MOORE CRAIG WDirector5,116$1.027.30%
12/05/2014Plavan Matthew TDirector-23,765$1.05-8.31%
9/30/2014STRACEY ROBIN CDirector5,738$1.2212.85%
9/30/2014MOORE CRAIG WDirector8,555$1.2213.90%
7/29/2014Plavan Matthew TCEO & Director-8,488$1.39-2.81%
7/29/2014Pappa KennethVP, Mfg, Eng and IT-5,508$1.39-5.98%
6/30/2014MOORE CRAIG WDirector7,509$1.3913.90%
6/30/2014STRACEY ROBIN CDirector5,036$1.3912.71%
3/31/2014MOORE CRAIG WDirector6,140$1.7012.82%
3/31/2014STRACEY ROBIN CDirector6,471$1.7019.51%
12/31/2013MOORE CRAIG WDirector5,393$1.0212.69%
12/31/2013STRACEY ROBIN CDirector9,070$1.0237.65%
9/30/2013STRACEY ROBIN CDirector7,870$1.0848.52%
9/30/2013MOORE CRAIG WDirector5,093$1.0813.62%
6/28/2013STRACEY ROBIN CDirector10,926$1.35206.38%
6/28/2013MOORE CRAIG WDirector5,926$1.3518.83%
3/28/2013MOORE CRAIG WDirector6,471$0.8525.88%
7/29/2011Rao Mahendra S.Director25,000$1.98400.00%
6/01/2011Plavan Matthew TCFO & EVP Business Development30,000$2.25218.18%
3/10/2011ENGLE J MELVILLEChairman & CEO22,500$2.3045.00%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (KOOL), click here.
Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!